Clinical trial

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan

NCT07537673

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-25

PhasePHASE2

Study timeline

Study start (actual)2025-11-25Date precision: day

Registry last updated2026-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Nausea and Vomiting Caused by Trastuzumab Deruxtecanunresolved

Interventions

Auricular point stimulation plus dexamethasoneOTHER

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Mapped research locations

HangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07537673 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.